ASND Q3'26 Earnings: EPS estimate is 0.89 USD

ASND (Ascendis Pharma A/S) is set to announce its Q3'26 results on November 12, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (2:30 PM UTC).For Q3'26, revenue estimate is 409.37 million USD with EPS (earnings per share) anticipated at 0.89 USD. Learn more details…